Product Description
Paxobrook Nirmatrelvir and Ritonavir Tablets Combipack is a powerful antiviral medication used for the treatment of COVID-19 caused by the SARS-CoV-2 virus. Each combipack contains 30 tablets, with 20 tablets of Nirmatrelvir and 10 tablets of Ritonavir. The tablets are suitable for adults who meet defined clinical criteria for antiviral treatment. The active ingredients include Nirmatrelvir 150 mg and Ritonavir 100 mg. It is recommended for COVID-19 patients with mild to moderate symptoms and should be taken as directed by a healthcare provider. The dosage typically involves taking 300 mg of Nirmatrelvir and 100 mg of Ritonavir twice daily for 5 days. The tablets should be stored below 25C in a dry place away from direct sunlight.
FAQs of Paxobrook Nirmatrelvir and Ritonavir Tablets Combipack:
Q: What is the function of Paxobrook Nirmatrelvir and Ritonavir Tablets Combipack?
A: The function of the combipack is to treat COVID-19 caused by the SARS-CoV-2 virus.
Q: How should the tablets be stored?
A: The tablets should be stored below 25C in a dry place away from direct sunlight.
Q: What is the recommended dosage for the combipack?
A: The recommended dosage is 300 mg of Nirmatrelvir and 100 mg of Ritonavir twice daily for 5 days.
Q: Who is the combipack suitable for?
A: The combipack is suitable for adults meeting defined clinical criteria for antiviral treatment.
Q: How many tablets are included in each combipack?
A: Each combipack contains 30 tablets, with 20 Nirmatrelvir tablets and 10 Ritonavir tablets.